Search results
Results from the WOW.Com Content Network
In the U.S., there are approximately 20 million cases of viral gastroenteritis each year. While most of us can manage the symptoms and recover at home without medical treatment, the infection can ...
The 24-hour flu is usually a type of gastroenteritis, ... virus that causes vomiting and diarrhea—and sometimes at the same time, according to the Centers for Disease Control and Prevention ...
Norovirus is a leading cause of acute gastroenteritis, or an inflammation of the lining of the stomach and intestines, according to the U.S. Centers for Disease Control and Prevention. This ...
Gastroenteritis is the main reason for 3.7 million visits to physicians a year in the United States [1] and 3 million visits in France. [81] In the United States gastroenteritis as a whole is believed to result in costs of US$23 billion per year, [82] with rotavirus alone resulting in estimated costs of US$1 billion a year. [1]
Norovirus, also known as Norwalk virus and sometimes referred to as the winter vomiting disease, is the most common cause of gastroenteritis. [ 1 ] [ 6 ] Infection is characterized by non-bloody diarrhea , vomiting , and stomach pain .
Gastroenteritis can be caused by viral, bacterial, or parasitic infections. Common routes of infection include: Food; Contaminated water; Contact with an infected person; Unwashed hands [2] Fifty to seventy percent of cases of gastroenteritis in adults are caused by noroviruses (genus Norovirus, family Caliciviridae). This virus is highly ...
“Norovirus is the leading cause of vomiting and diarrhea from acute gastroenteritis in the U.S., responsible for 58% of foodborne illnesses and about 2,500 outbreaks annually,” Justman says.
For treating eosinophilic gastroenteritis, the main treatment is usually a corticosteroid medication, as these have been shown to have good efficacy in managing eosinophilic gastroenteritis. Other treatments include modifying diets to avoid food allergies, azathioprine and antibodies, including mepolizumab , omalizumab , infliximab , and ...